Tata Elxsi · forward-looking guidance across the available source record.
Guidance tracker
Management maintained guidance for high single-digit revenue growth in FY27, contingent on healthcare segment firing up alongside continued strength in Transportation and Media & Communications verticals.
Q2 margins will reflect wage hike costs offset by ~150bps of one-time costs going away, with sequential improvement expected through Q3-Q4 as revenue scales and ramp-up costs normalize.
Neuron platform enabled Sky UK to achieve 30-70% efficiencies in network operations with enhanced cybersecurity; AIEL's Vital platform signed strategic deal with global medtech company.
On-site subcontractor costs (90bps shift in offshore ratio) incurred due to visa delays and deal transition timelines will be replaced by own employees or moved offshore, normalizing within 2-3 quarters.
Management expressed confidence that H2 will deliver meaningfully higher revenue growth compared to H1, with margin recovery as utilization improves to 75% by year-end. Wage hikes planned for Q3 will be absorbed while still showing margin improvement versus H1.
Management expects both Transportation and Healthcare verticals to deliver double-digit growth in FY27, supported by new deal ramp-ups (Suzuki, Mercedes-Benz, Bayer), expanding customer diversification beyond tier-1 suppliers to OEMs, and strengthening sales and delivery capabilities.
The company has already improved utilization from ~66% to 70%+ and is focused on reaching 75% by fiscal year-end, which management identifies as the key lever for margin recovery before targeting 80% in FY27.
The recently announced Suzuki cloud/hardware/simulation center in Tiruvanandapuram and the Bayer radiology technology center are both 5-10 year engagements expected to peak headcount after 6-8 quarters, representing multi-million dollar revenue streams.
Management maintains internal aspiration for double-digit growth in both Transportation and Healthcare verticals for FY27, contingent on strong momentum in Q4 and Q1 next year.
Management expects positive signs in Media & Communications during Q4 FY26, with large deal outcomes expected to be announced. The large deals won earlier have ramped up and the pipeline remains healthy.
CFO indicated confidence in moving back to margins Tata Elxsi previously operated at (implying pre-dip levels) by the exit of next fiscal year, leveraging utilization improvement and operating leverage.
Company will continue calibrated hiring for specific skill sets but large-scale hiring is deferred for at least 1-2 quarters while leveraging utilization improvement from current 75% towards 80%+.
Management expects high single-digit revenue growth for FY27, down from earlier double-digit aspiration, due to geopolitical uncertainty and delayed deal closures.
Management targets exiting FY27 with ~27% EBITDA margin, driven by operational efficiencies, utilization improvement, and AI adoption.
Management expects healthcare vertical to recover in Q1 FY27 as delayed deals close, aiming for positive growth over Q2-Q3 combined.